Owonikoko, T. K., Papadopoulos, K. P., Johnson, M. L. and al., E. (2018) “Phase 1 Study of Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Unresectable Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma (CSCC): Final Efficacy and Safety Data”, SKIN The Journal of Cutaneous Medicine, 20, p. S78. doi: 10.25251/skin.2.supp.78.